Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolcapone Treatment of Pathological Gambling
NCT00927563Phase 2Completed
- Sponsor
- University of Chicago
- Start
- Jun 2009
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tolcapone in gambling disorder (GD), sponsored by University of Chicago. Started Jun 2009; status: completed.
02
Drugs
tolcapone
03
Conditions
gambling disorder (GD)
Beyond the preview
Go deeper on NCT00927563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00927563.